Tyro3 Targeting as a Radiosensitizing Strategy in Bladder Cancer through Cell Cycle Dysregulation

Bladder cancer is a common cancer; it is the tenth most common cancer in the world. Around one fourth of all diagnosed patients have muscle-invasive bladder cancer (MIBC), characterized by advanced tumors and which remains a lethal disease. The standard treatment for MIBC is the bladder removal by s...

Descripción completa

Detalles Bibliográficos
Autores principales: Silina, Linda, Dufour, Florent, Rapinat, Audrey, Reyes, Cécile, Gentien, David, Maksut, Fatlinda, Radvanyi, François, Verrelle, Pierre, Bernard-Pierrot, Isabelle, Mégnin-Chanet, Frédérique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368768/
https://www.ncbi.nlm.nih.gov/pubmed/35955805
http://dx.doi.org/10.3390/ijms23158671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368768/
https://www.ncbi.nlm.nih.gov/pubmed/35955805
http://dx.doi.org/10.3390/ijms23158671

Ejemplares similares